May 22, 2024

Generative AI in Healthcare Market Size Analysis 2023 To 2032

The global generative AI in healthcare market size accounted for US$ 1.07 Bn in 2022 and is projected to reach around USD 21.74  Bn by 2032, growing at a CAGR of 35.14% from 2023 to 2032.

Generative AI in Healthcare Market Size 2023 To 2032

Key Takeaways:

  • North America contributed more than 37% of the revenue share in 2022.
  • Asia Pacific will witness significant growth during the forecast period.
  • By application, the clinical segment is expected to grow at a significant rate during the forecast period.
  • By function, the image analysis segment is predicted to dominate the market with the largest share during the forecast period.
  • By end-user, the diagnostic centers’ segment is expected to lead the market in the analyzed timeframe.

Report Summary

The global generative AI in healthcare market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the generative AI in healthcare market across the globe.

A comprehensive estimate on the generative AI in healthcare market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of generative AI in healthcare during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3099

Generative AI in Healthcare Market Report Scope 

Report CoverageDetails
Market Size in 2023USD 1.45 Billion
Market Size by 2032USD 21.74 Billion
Growth Rate from 2023 to 2032CAGR of 35.14%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Application, By Function, and By End User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized generative AI in healthcare market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: 3D Printing Medical Devices Market Size Analysis 2023 To 2032

Generative AI in Healthcare Market Players

The report includes the profiles of key generative AI in healthcare market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Syntegra
  • NioyaTech
  • Saxon
  • IBM Watson
  • Microsoft Corporation
  • Google LLC
  • Tencent Holdings Ltd.
  • Neuralink Corporation
  • Johnson & Johnson
  • OpenAI
  • Oracle

Market Segmentation

By Application

  • Clinical
    • Cardiovascular
    • Dermatology
    • Infectious Disease
    • Oncology
    • Others
  • System
    • Disease Diagnosis
    • Telemedicine
    • Electronic Health Records
    • Drug Interaction

By Function

  • AI-Assisted Robotic Surgery
  • Virtual Nursing Assistants
  • Aid Clinical Judgment/Diagnosis
  • Workflow & Administrative Tasks
  • Image Analysis

By End User

  • Hospitals & Clinics
  • Clinical Research
  • Healthcare Organizations
  • Diagnostic Centers
  • Others

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Generative AI in Healthcare Market 

5.1. COVID-19 Landscape: Generative AI in Healthcare Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Generative AI in Healthcare Market, By Application

8.1. Generative AI in Healthcare Market, by Application, 2023-2032

8.1.1 Clinical

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. System

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Generative AI in Healthcare Market, By Function

9.1. Generative AI in Healthcare Market, by Function, 2023-2032

9.1.1. AI-Assisted Robotic Surgery

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Virtual Nursing Assistants

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Aid Clinical Judgment/Diagnosis

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Workflow & Administrative Tasks

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Image Analysis

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Generative AI in Healthcare Market, By End User 

10.1. Generative AI in Healthcare Market, by End User, 2023-2032

10.1.1. Hospitals & Clinics

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Clinical Research

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Healthcare Organizations

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Diagnostic Centers

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Generative AI in Healthcare Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.2. Market Revenue and Forecast, by Function (2020-2032)

11.1.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Function (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Function (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.2. Market Revenue and Forecast, by Function (2020-2032)

11.2.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Function (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Function (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Function (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Function (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.2. Market Revenue and Forecast, by Function (2020-2032)

11.3.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Function (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Function (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Function (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Function (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.2. Market Revenue and Forecast, by Function (2020-2032)

11.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Function (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Function (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Function (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Function (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.2. Market Revenue and Forecast, by Function (2020-2032)

11.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Function (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Function (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End User (2020-2032)

Chapter 12. Company Profiles

12.1. Syntegra

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. NioyaTech

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Saxon

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. IBM Watson

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Microsoft Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Google LLC

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Tencent Holdings Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Neuralink Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Johnson & Johnson

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. OpenAI

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com